© 2021 MJH Life Sciences and Cancer Network. All rights reserved.
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
January 17, 2019
Our team reviews the most important advances in oncology in 2018, including those in breast cancer, hematologic cancers, lung cancer, immunotherapy, and more.
Our team reviews 2018 conference highlights in oncology care, including studies from ASH, SABCS, and SIO.
An oncology pharmacist discusses how to manage neutropenic toxicity from treatment with CDK4/6 inhibitors for HR-positive breast cancer.
In this case, we examine a 49-year-old man with widespread metastatic sclerotic bone lesions. What is your diagnosis?